explore -WSS

explore

author：fashion 2025-10-06 17:35:37 - browse：39

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid.

But what if long Covid isn’t the right way to think about what they are going through?

On this episode of the First Opinion Podcast, I spoke with Steven Phillips and Michelle A. Williams, authors of a recent First Opinion essay titled, “Long Covid is a new name for an old syndrome.” Steven is a Global Virus Network board member and vice president for science and strategy at the COVID Collaborative; Michelle is the former dean and current Joan and Julius Jacobson professor of epidemiology and public health at the Harvard T.H. Chan School of Public Health.

“Michelle and I have come up with basically a new paradigm that says long Covid is really an old disease, and the more you do deep dives into the history of chronic fatigue syndrome and post-infectious fatigue syndromes, the more you realize that not only are there similarities, but the level of congruence between the two is strikingly high,” Steven said.

The purpose of this new paradigm is to “break the logjam” of the current long Covid discourse and “to try to provide a framework whereby people would think about long Covid in a different way in a way that would be more productive,” Michelle told me.

We discussed the history of post-infectious disease syndrome, what rethinking long Covid might mean for research, and the ways the health care system fails chronically ill patients.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Biogen’s boardroom scandal saddles CEO with first crisis

leisure time

WSS

AI gets buy

What to know about the judge who will handle the Trump case

Surge in Apellis stock fueled by confidence in safety of its eye drug

Global cancer cases to surge 77% by 2050, WHO report says

Patients, digital health players weigh in on FTC's data privacy plan

What to know about the judge who will handle the Trump case

hotspot

explore

leisure time

23andMe had bad news about my health. I wish a person had delivered it

Treatments for cramps don't cut it. Why aren't there better options?

ChatGPT in medicine: STAT answers readers' burning questions

Top private equity targets in 2023: cardiology, clinical trials, lasers

New air purifier tech could be key to improving indoor air quality

Global cancer cases to surge 77% by 2050, WHO report says

Supreme Court strikes down use of affirmative action

Novo Nordisk touts Wegovy study, but still struggling with supply

Medical records are filled with copy

Health AI: on the border between health care and tech

focus

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Readout LOUD: Venture capital, Gilead, and more M&A

Patients, digital health players weigh in on FTC's data privacy plan

Patients, digital health players weigh in on FTC's data privacy plan

Illinois Supreme Court finds assault weapons ban constitutional

Gene therapy for Afghan refugees’ infant will be fully covered

focus

leisure time

explore

explore